Derivative works

This Defensive Disclosure document aims to define prior art that would render future incremental improvements on US Patent 11,021,737 "obvious" or "non-novel" to a Person Having Ordinary Skill in the Art (PHOSITA). The analysis focuses on deriving variations from the core independent claims (Claim 1, Claim 12, and Claim 20) of the patent.

Derivative Variations of US Patent 11,021,737

The following derivatives explore alternative materials, operational scales, cross-domain applications, integration with emerging technologies, and inverse/failure modes for the methods and compositions described in US Patent 11,021,737.

---

Derivatives for Claim 1 (Method for detecting a plurality of analytes in a sample):

Claim 1 describes a method involving contacting a sample with detection reagents (probe + nucleic acid label with subsequences) and detecting these subsequences in a temporally-sequential manner to identify analytes.

Derivative 1.1: All-RNA Detection System

• Enabling Description: Instead of DNA nucleic acid labels, employ RNA oligonucleotides for the nucleic acid labels attached to probe reagents. The probe reagents (e.g., antibodies, aptamers) would be conjugated to single-stranded RNA sequences containing the predetermined subsequences. Detection would involve RNA-RNA hybridization with complementary decoder RNA probes, or RNA-DNA hybridization with DNA decoder probes. Ribonucleases (RNases) with specific cleavage sites could be engineered into the RNA labels or decoder probes for signal removal/displacement, replacing DNA-specific enzymes like USER. The matrix material for in-situ applications could be an alginate hydrogel optimized for RNA stability, perhaps with RNase inhibitors, allowing for the preservation of fragile native RNA analytes.
• Mermaid Diagram:

  sequenceDiagram
      participant Sample
      participant RNA_Probe_Reagent as Detection Reagent (Probe+RNA Label)
      participant RNA_Decoder_Probes as RNA Decoder Probes
      participant Imaging_System as Imaging System
      
      Note over Sample, RNA_Probe_Reagent: Contact sample with RNA detection reagents
      RNA_Probe_Reagent->>Sample: Bind to target analyte
      Note over RNA_Decoder_Probes: Apply Set 1 of RNA decoder probes (labeled)
      RNA_Decoder_Probes->>RNA_Probe_Reagent: Hybridize to subsequence 1
      Imaging_System->>RNA_Decoder_Probes: Detect Signal 1
      Note over RNA_Decoder_Probes: Remove Set 1 RNA decoder probes (e.g., RNase cleavage, heat)
      Note over RNA_Decoder_Probes: Apply Set 2 of RNA decoder probes (labeled)
      RNA_Decoder_Probes->>RNA_Probe_Reagent: Hybridize to subsequence 2
      Imaging_System->>RNA_Decoder_Probes: Detect Signal 2
      Note over Imaging_System: Continue sequentially for all subsequences
      Imaging_System->>Imaging_System: Generate temporal order of signals
      Imaging_System->>RNA_Probe_Reagent: Identify probe reagent / analyte
  

Derivative 1.2: High-Throughput Microfluidic System for Industrial-Scale Bioprocessing Monitoring

• Enabling Description: The method is scaled for real-time, high-throughput monitoring of bioprocessing vats (e.g., 10,000L fermenters). Samples (e.g., microbial cell suspensions, culture media) are continuously drawn into a microfluidic device, featuring channels approximately 50-100 µm wide. Detection reagents are introduced at high flow rates (e.g., 1-10 mL/min). The detection reagents are designed with highly stable (e.g., LNA-modified) nucleic acid labels to withstand harsh industrial conditions (e.g., pH 4-9, temperatures up to 60°C). Detection occurs within a dedicated "detection chamber" with multiple, spatially offset laser excitation and detection zones, allowing for rapid, pseudo-simultaneous temporal decoding across a continuous flow. The temporal detection sequence for each reagent must be completed within milliseconds as particles flow through the detection zone. The system uses high-frequency pulsed lasers (e.g., 10 kHz) and synchronized high-speed cameras (e.g., 10,000 frames/sec) to capture rapid signal changes. Data processing involves real-time algorithmic identification of temporal signal patterns from thousands of individual reagents per second.
• Mermaid Diagram:

  graph TD
      A[Bioprocess Vat] --> B(Microfluidic Sample Inlet)
      B --> C{Mixing Chamber: Sample + Detection Reagents}
      C --> D[Microfluidic Flow Channel]
      D -- High-Speed Flow --> E1(Detection Zone 1: Laser Excitation + Camera)
      E1 -- Milliseconds Later --> E2(Detection Zone 2: Wash + Next Decoder Probe Application)
      E2 -- Milliseconds Later --> E3(Detection Zone 3: Laser Excitation + Camera)
      E3 -- Sequential Operation --> E_N(Detection Zone N)
      E_N --> F[High-Speed Data Processing & Analysis]
      F --> G{Real-time Analyte Identification & Quantification}
      F --> H(Process Control System)
      H --> A
  

Derivative 1.3: Environmental Contaminant Monitoring in Water Treatment (Cross-Domain)

• Enabling Description: The method is applied to detect a plurality of specific environmental contaminants (analytes) in large-volume water samples (e.g., municipal water treatment plants, industrial effluent). Probe reagents would include: 1. Aptamers engineered to bind specific heavy metal ions (e.g., Pb2+, Hg2+). 2. Antibodies targeting residues of pesticides (e.g., glyphosate, atrazine) or pharmaceuticals (e.g., ibuprofen, diclofenac). 3. Bacteriophages/Antibodies targeting specific bacterial pathogens (e.g., E. coli O157:H7, Legionella pneumophila). These probe reagents are conjugated to unique nucleic acid labels. Water samples are continuously passed through a filtration system to concentrate particulate matter (e.g., bacteria, microplastics with adsorbed contaminants) or directly introduced for dissolved analytes. Detection reagents are added, allowed to bind, and unbound reagents are flushed. The remaining bound reagents are then subjected to temporal decoding using fluorescently-labeled decoder probes and automated fluidic systems. The generated temporal signatures indicate the presence and concentration of various contaminants.
• Mermaid Diagram:

  flowchart TD
      A[Water Sample Inlet] --> B{Filtration/Concentration (Optional)}
      B --> C[Mixing Chamber: Sample + Detection Reagents]
      C --> D{Incubation for Analyte Binding}
      D --> E{Wash: Remove Unbound Reagents}
      E --> F[Automated Fluidic System for Temporal Decoding]
      F -- Step 1: Add Decoder Probe Set 1 --> G1(Image Capture 1)
      G1 -- Remove Signal 1 --> F
      F -- Step 2: Add Decoder Probe Set 2 --> G2(Image Capture 2)
      G2 -- ... --> F
      F -- Final Step: Add Decoder Probe Set N --> GN(Image Capture N)
      GN --> H[Data Analysis: Temporal Signature Identification]
      H --> I{Contaminant Report: Type & Concentration}
      I --> J(Alert System for Water Quality)
  

Derivative 1.4: Livestock Disease Monitoring (AgriTech - Cross-Domain)

• Enabling Description: The method is used for rapid, multiplexed detection of pathogens and stress markers in livestock. Samples include blood, saliva, milk, or fecal matter from individual animals or pooled samples from herds. Probe reagents include antibodies or aptamers specific to: 1. Viral antigens, e.g., Foot-and-mouth disease virus (FMDV) proteins, Avian Influenza H5N1 proteins. 2. Bacterial toxins, e.g., E. coli enterotoxins, Salmonella LPS. 3. Hormones/Metabolites, e.g., cortisol as a stress indicator, specific inflammatory cytokines. Detection reagents with their unique nucleic acid labels are applied to prepared samples (e.g., on a microarray slide for pooled samples or directly in a microfluidic cartridge for individual animal diagnosis). After binding and washing, automated temporal decoding identifies the presence and relative abundance of disease agents or stress markers, enabling early intervention and herd management.
• Mermaid Diagram:

  flowchart LR
      A[Animal Sample (Blood/Saliva/Milk)] --> B{Sample Preparation (e.g., Centrifugation, Lysis)}
      B --> C[Microarray/Microfluidic Device]
      C --> D{Contact with Detection Reagents}
      D -- Bind to Analytes --> E{Wash Unbound Reagents}
      E --> F[Automated Temporal Decoding Module]
      F -- Cycle 1: Hybridize Decoder 1 --> G1(Capture Image 1)
      G1 -- Remove Signal 1 --> F
      F -- Cycle 2: Hybridize Decoder 2 --> G2(Capture Image 2)
      G2 -- ... --> F
      F --> H[Data Analysis: Disease/Stress Marker ID]
      H --> I{Veterinary Diagnostic Report}
      I --> J(Herd Management Decision Support)
  

Derivative 1.5: Authenticity Verification in Luxury Goods (Consumer Electronics/Supply Chain - Cross-Domain)

• Enabling Description: To combat counterfeiting, luxury goods (e.g., designer handbags, high-end electronics components) are invisibly marked with microscopic, unique "authenticity tags." These tags are composed of an inert polymer particle (e.g., nanodiamond, quantum dot embedded polymer bead) acting as the "probe reagent" (though not binding to an analyte, it is the item of interest) and are surface-conjugated with multiple identical, custom-synthesized nucleic acid labels. Each batch or individual item receives tags with a unique "temporal barcode" encoded in its nucleic acid labels. For verification, a minute sample is taken from the item (e.g., by swab, micro-abrasion) and introduced into a portable detection device. Detection reagents (here, the authenticity tags) are then analyzed via temporal decoding of their nucleic acid labels using fluorescent decoder probes. The detected temporal sequence is compared against a secure database of legitimate product codes. This allows for rapid, unambiguous authentication, even for high volumes of goods. The "analyte" is the unique authenticity tag itself.
• Mermaid Diagram:

  graph TD
      A[Luxury Good] --> B(Micro-sampling/Swab)
      B --> C[Portable Detection Device]
      C --> D{Isolate Authenticity Tags}
      D --> E[Automated Fluidics: Temporal Decoding]
      E -- Cycle 1: Add Decoder Probe Set 1 --> F1(Image Capture 1)
      F1 -- Remove Signal 1 --> E
      E -- Cycle 2: Add Decoder Probe Set 2 --> F2(Image Capture 2)
      F2 -- ... --> E
      E --> G[Decode Temporal Barcode]
      G --> H{Compare with Secure Blockchain Database}
      H -- Match --> I(Authentic Product)
      H -- No Match --> J(Counterfeit Detected)
  

Derivative 1.6: AI-Optimized Real-time Spatial Profiling (Integration with Emerging Tech)

• Enabling Description: The method is integrated with an AI-driven imaging and fluidics control system for advanced spatial biology. IoT sensors (e.g., embedded temperature, pH, fluid flow sensors) in a microfluidic chip provide real-time environmental data. An AI agent (e.g., deep reinforcement learning model) dynamically optimizes the experimental parameters during temporal detection: 1. Decoder Probe Incubation Times: Adjusted based on real-time binding kinetics and signal intensity observed. 2. Wash Stringency: Optimized based on unspecific binding levels and desired removal efficiency. 3. Fluorophore Excitation Power/Duration: Minimized to prevent photobleaching while ensuring adequate signal-to-noise. 4. Z-stack Imaging Depth/Frequency: Adjusted based on tissue heterogeneity and signal localization. The AI processes raw image data (e.g., 3D fluorescent images) in real-time, performing signal deconvolution, drift correction, and temporal pattern recognition. It then reconstructs a 3D spatial map of multiple analytes, presenting quantification and co-localization data. This autonomous system significantly improves detection speed, accuracy, and resolution, especially for complex or sparse analyte distributions.
• Mermaid Diagram:

  graph TD
      A[Biological Sample (Tissue Slice)] --> B{Microfluidic Chamber with IoT Sensors}
      B --> C[Detection Reagents]
      C -- Bind Analytes --> D[Automated Fluidics Control]
      D -- Apply/Wash Decoder Probes --> E[High-Res 3D Imaging System]
      E -- Real-time Image Data --> F(AI Optimization Engine)
      F -- Environmental Data --> F
      F -- Control Signals --> D
      F --> G[Signal Deconvolution & Temporal Pattern Recognition]
      G --> H[3D Spatial Map of Analytes]
      H --> I(Visualization & Quantification Interface)
  

Derivative 1.7: Blockchain for Supply Chain Provenance of Biomolecules (Integration with Emerging Tech)

• Enabling Description: The patent's method is adapted to verify the provenance and integrity of critical biomolecule reagents (e.g., antibodies, enzymes, synthetic oligonucleotides) throughout a cold chain supply. Each batch of a biomolecule is internally "barcoded" by conjugating a small, known fraction of the biomolecule to a specific nucleic acid label with a unique temporal signature. This signature is then recorded as a transaction on a private blockchain. At various checkpoints in the supply chain (e.g., manufacturing, shipping, distribution, end-user QC), a small sample of the reagent is taken, and its internal nucleic acid labels are temporally decoded. The resulting temporal signature is hashed and compared to the blockchain record. Any discrepancy (e.g., incorrect signature, missing signature, degradation leading to altered signal intensity) flags a potential counterfeit, contamination, or breach in the cold chain. This provides an immutable, verifiable audit trail.
• Mermaid Diagram:

  sequenceDiagram
      actor Manufacturer
      participant ReagentBatch as Biomolecule Reagent Batch
      participant DNA_Labeling as DNA Barcoding Module
      participant Blockchain as Blockchain Network
      participant QC_Check1 as QC Checkpoint 1
      participant QC_CheckN as QC Checkpoint N
      actor EndUser
      
      Manufacturer->>ReagentBatch: Produce Biomolecule
      DNA_Labeling->>ReagentBatch: Conjugate unique SeqTag to aliquot
      DNA_Labeling->>Blockchain: Record SeqTag Hash (Batch ID, Timestamp)
      ReagentBatch->>QC_Check1: Ship to Distributor
      Note over QC_Check1: Sample & Decode SeqTag (Claim 1 method)
      QC_Check1->>Blockchain: Verify SeqTag Hash
      alt Verification Fails
          QC_Check1->>Blockchain: Record Tamper Event
          QC_Check1->>Manufacturer: Alert: Integrity Compromised
      else Verification Succeeds
          QC_Check1->>ReagentBatch: Continue Shipment
      end
      ...
      ReagentBatch->>QC_CheckN: Ship to End User
      QC_CheckN->>Blockchain: Verify SeqTag Hash
      EndUser->>Blockchain: Final Verification
  

Derivative 1.8: Self-Deactivating/Limited-Functionality Diagnostic for Point-of-Care (The "Inverse" or Failure Mode)

• Enabling Description: Develop a point-of-care (POC) diagnostic kit using the temporal detection method, designed to operate in a limited-functionality mode after initial use or to self-deactivate for safe disposal and privacy. The nucleic acid labels on the detection reagents are engineered with multiple cleavable sites (e.g., UV-cleavable linkers, specific restriction enzyme sites) interspersed within the subsequences or at the probe-label conjugation point. After a predetermined number of detection cycles (e.g., sufficient for a single diagnostic readout, say 3 cycles), a "deactivation reagent" (e.g., a UV light pulse, a specific enzyme solution) is automatically introduced. This reagent cleaves the nucleic acid labels or the linker, irreversibly destroying the barcode information and preventing further or unauthorized detection. In a "low-power" mode, only the first 1-2 subsequences are decoded, providing a rapid "yes/no" or "high/low" qualitative result, consuming fewer reagents and less power, before self-deactivation. This ensures patient data privacy and prevents re-use of diagnostic components.
• Mermaid Diagram:

  stateDiagram-v2
      [*] --> Initialized: Kit Ready
      Initialized --> Sample_Added: Sample Contact
      Sample_Added --> Analyte_Binding: Detection Reagents Bind
      Analyte_Binding --> Temporal_Decoding_Cycle_1: Start Decoding
      Temporal_Decoding_Cycle_1 --> Signal_Capture_1: Detect Subsequence 1
      Signal_Capture_1 --> Decoder_Removal_1: Remove Decoder 1
      Decoder_Removal_1 --> Temporal_Decoding_Cycle_2: If More Cycles Needed
      Temporal_Decoding_Cycle_2 --> Signal_Capture_2: Detect Subsequence 2
      Signal_Capture_2 --> Decoder_Removal_2: Remove Decoder 2
      Decoder_Removal_2 --> Temporal_Decoding_Cycle_N: If More Cycles Needed (N <= Max Cycles)
      Temporal_Decoding_Cycle_N --> Final_Signal_Capture: Final Detection
      Final_Signal_Capture --> Interpretation: Analyze Results
      Interpretation --> Deactivation_Triggered: Max Cycles Reached OR Readout Complete
      Deactivation_Triggered --> Barcode_Irreversible_Cleavage: Apply Deactivation Reagent
      Barcode_Irreversible_Cleavage --> [*]: Self-Deactivated / Dispose
      
      Temporal_Decoding_Cycle_1 --> Low_Power_Mode: (Optional) Limit Cycles
      Low_Power_Mode --> Limited_Readout: Fast Qualitative Result
      Limited_Readout --> Deactivation_Triggered
  

Derivative 1.9: Quantum Dot-Encoded Decoder Probes with Hyperspectral Imaging (Material & Component Substitution)

• Enabling Description: Instead of organic fluorescent dyes, the decoder probes are labeled with quantum dots (QDs). Each set of decoder probes uses QDs emitting at distinct, narrow wavelengths when excited by a broad-spectrum light source, or uses QDs with varying excitation/emission characteristics that are distinguishable. For instance, a set of 4 decoder probes might use QDs emitting at 520 nm, 580 nm, 620 nm, and 680 nm. Detection is performed using a hyperspectral imaging system capable of resolving multiple distinct emission spectra simultaneously in each temporal step. This provides higher spectral resolution, greater photostability, and reduced bleed-through compared to traditional fluorophores, allowing for more multiplexing within a single temporal step and more robust signal detection over many cycles. Signal removal could involve UV degradation of the QD's surface passivation layer, or enzymatic cleavage of a linker attaching the QD to the probe.
• Mermaid Diagram:

  graph TD
      A[Detection Reagents Bound to Analytes] --> B{Apply QD Decoder Probes (Set 1)}
      B --> C[Hyperspectral Imaging System]
      C -- Capture Multiple Wavelengths --> D{Detect Temporal Signal 1 (Spectral Signature)}
      D --> E{Remove QD Decoder Probes 1}
      E --> F{Apply QD Decoder Probes (Set 2)}
      F --> C
      C -- Capture Multiple Wavelengths --> G{Detect Temporal Signal 2 (Spectral Signature)}
      G --> H[Temporal Sequence of Spectral Signatures]
      H --> I(Analyte Identification)
  

Derivative 1.10: Ultra-low Temperature/Cryogenic Sample Processing (Operational Parameter Expansion)

• Enabling Description: The method is adapted for detecting analytes in cryogenically preserved samples, or performing detection steps at ultra-low temperatures (e.g., -80°C to -196°C, within a cryostat). This would be beneficial for preserving delicate analytes, minimizing diffusion, or studying cellular processes at extremely low metabolic rates. The detection reagents and decoder probes would need to be synthesized with cryo-compatible modifications (e.g., increased GC content for nucleic acids to maintain hybridization strength at lower temperatures, specific cryoprotectant formulations). The matrix material for in-situ applications would be a cryogel or cryo-resistant polymer (e.g., highly cross-linked polyacrylamide with glycerol). Fluidics systems would need to handle cryogenic liquids (e.g., ethanol, specialized buffers). Imaging systems would be integrated into the cryostat, using specialized optics for low-temperature environments. Signal removal (e.g., displacement hybridization) would be optimized for slow diffusion kinetics at these temperatures.
• Mermaid Diagram:

  flowchart TD
      A[Cryo-preserved Sample] --> B{Cryostat Integration & Sample Thawing/Preparation (if needed)}
      B --> C[Cryo-compatible Detection Reagents]
      C -- Bind Analytes at Low Temp --> D{Cryo-Fluidics: Wash Unbound Reagents}
      D --> E[Cryo-Imaging Module (Integrated within Cryostat)]
      E -- Cycle 1: Apply Cryo-Decoder 1 --> F1(Cryo-Image 1)
      F1 -- Remove Signal 1 (optimized for cryo) --> E
      E -- Cycle N: Apply Cryo-Decoder N --> FN(Cryo-Image N)
      FN --> G[Low-Temperature Data Analysis]
      G --> H(Analyte Detection Report)
  

---

Derivatives for Claim 12 (Method for detecting via hybridization and removal):

Claim 12 further specifies the detection method of Claim 1, detailing the sequential hybridization, detection, and optional removal of decoder probes.

Derivative 12.1: Self-Assembling DNA-Origami Decoder Probes (Material & Component Substitution)

• Enabling Description: Instead of linear oligonucleotide decoder probes, utilize complex DNA-origami structures as decoder probes. Each DNA-origami structure is precisely engineered to present multiple copies of a specific hybridization sequence complementary to a subsequence on the detection reagent's nucleic acid label. The origami structures also integrate multiple copies of specific, spatially arranged detectable labels (e.g., a cluster of 10 fluorescent molecules or a single, large quantum dot). This multivalency significantly increases binding affinity and signal intensity. Signal removal could involve inducing a structural change in the DNA origami (e.g., via a "trigger" oligonucleotide that causes dissociation) or enzymatic degradation specifically targeting the origami structure, leaving the detection reagent intact.
• Mermaid Diagram:

  classDiagram
      class DetectionReagent {
          +ProbeReagent
          +NucleicAcidLabel (w/ Subsequences)
      }
      
      class DNA_Origami_Decoder {
          +HybridizationSequence[]
          +DetectableLabel[]
          +StructuralTriggerSite
      }
      
      DetectionReagent "1" -- "1" NucleicAcidLabel
      NucleicAcidLabel "1" -- "*" Subsequence
      DNA_Origami_Decoder "1" -- "*" HybridizationSequence
      DNA_Origami_Decoder "1" -- "*" DetectableLabel
      
      Note for DNA_Origami_Decoder "Increased signal strength and binding affinity due to multivalency."
  

Derivative 12.2: Millimeter-Wave Spectroscopy for Label Detection in Opaque Samples (Operational Parameter Expansion)

• Enabling Description: For detection in optically opaque or highly scattering samples (e.g., dense tissue, whole blood, turbid fermentation broth), replace optical labels and fluorescence imaging with labels detectable by millimeter-wave (MMW) spectroscopy. Decoder probes are conjugated to specific MMW-resonant tags (e.g., metamaterial resonators, specially engineered nanoparticles with distinct dielectric properties, or molecular tags exhibiting unique rotational spectra in the MMW range). The detectable "signal signature" is a unique MMW absorption or reflection spectrum. A MMW transceiver system scans the sample, and the temporal order of detected MMW signatures identifies the analytes. Signal removal could involve chemical degradation of the MMW tags or altering their resonant properties via a pH/redox shift. This allows for deep penetration and detection without optical transparency requirements.
• Mermaid Diagram:

  graph LR
      A[Opaque Sample] --> B(Detection Reagents Bound)
      B --> C{MMW Transceiver System}
      C -- Emit MMW Signal --> D[MMW-Resonant Decoder Probes (Set 1)]
      D -- Absorb/Reflect MMW --> C
      C --> E{Detect MMW Signal 1 (Spectral Signature)}
      E --> F{Remove MMW Decoder Probes 1}
      F --> G{Apply MMW-Resonant Decoder Probes (Set 2)}
      G --> C
      C --> H{Detect MMW Signal 2 (Spectral Signature)}
      H --> I[Temporal Sequence of MMW Signatures]
      I --> J(Analyte Identification in Opaque Medium)
  

Derivative 12.3: Environmental Soil Contaminant Mapping (Geospatial/Environmental - Cross-Domain)

• Enabling Description: The method is used to create high-resolution 3D maps of contaminants within soil or sediment cores. Soil cores are collected, stabilized with a porous polymer (e.g., modified polyacrylamide gel to maintain structure), and then sectioned. Detection reagents (e.g., antibodies/aptamers against heavy metals, pesticides, petroleum hydrocarbons, radionuclides) are diffused into the soil sections. After binding and washing, sequential hybridization and removal of colorimetric or chemiluminescent decoder probes are performed. An automated imaging system captures the temporal signal signatures across the section, allowing for a detailed 3D reconstruction of contaminant distribution and concentration. This enables targeted remediation efforts.
• Mermaid Diagram:

  flowchart TD
      A[Soil Core Sample] --> B{Porous Polymer Stabilization & Sectioning}
      B --> C[Diffusion Chamber: Add Detection Reagents]
      C --> D{Incubation & Wash}
      D --> E[Automated Planar Imaging System]
      E -- Cycle 1: Apply Colorimetric Decoder 1 --> F1(Color Image 1)
      F1 -- Chem. Remove Signal 1 --> E
      E -- Cycle N: Apply Colorimetric Decoder N --> FN(Color Image N)
      FN --> G[3D Reconstruction & Contaminant Map]
      G --> H(Targeted Remediation Planning)
  

Derivative 12.4: Robotic Automation and Digital Twin Modeling (Integration with Emerging Tech)

• Enabling Description: The entire temporal detection process (fluidics, imaging, signal removal) is performed by a fully autonomous robotic platform. This robot operates within a sealed environment, handling delicate biological samples (e.g., brain slices, organoids). A digital twin of the biological sample and the experimental setup is created in real-time. This digital twin precisely models fluid dynamics, reagent diffusion, and light interaction within the sample. AI algorithms use this digital twin to predict optimal decoder probe concentrations, incubation times, and wash cycles for each specific tissue region, adapting to local variations. The temporal sequence of images is captured, processed, and immediately integrated into the digital twin, allowing for interactive, multi-dimensional analysis and simulation of experimental outcomes.
• Mermaid Diagram:

  sequenceDiagram
      actor Robotic_Platform
      participant Sample_Handling as Robotic Sample Handler
      participant Fluidics_Module as Automated Fluidics
      participant Imaging_Module as High-Res Imaging
      participant Digital_Twin_AI as Digital Twin & AI Optimizer
      
      Robotic_Platform->>Sample_Handling: Load Sample
      Sample_Handling->>Fluidics_Module: Deliver Detection Reagents
      Fluidics_Module->>Sample_Handling: Incubate & Wash
      loop Temporal Decoding Cycles
          Fluidics_Module->>Imaging_Module: Apply Decoder Probe Set (N)
          Imaging_Module->>Digital_Twin_AI: Stream Real-time Images
          Digital_Twin_AI->>Digital_Twin_AI: Update Digital Twin State
          Digital_Twin_AI->>Fluidics_Module: Adjust Fluidics/Imaging Parameters (AI Optimization)
          Fluidics_Module->>Sample_Handling: Remove Decoder Probe Set (N)
      end
      Digital_Twin_AI->>Robotic_Platform: Output 3D Analyte Map
  

Derivative 12.5: "Sentinel" Detection Reagents with Early Warning Degradation (The "Inverse" or Failure Mode)

• Enabling Description: Incorporate "sentinel" detection reagents into a multiplex assay. These sentinel reagents are designed to bind a common, stable cellular component (e.g., actin, ribosomal RNA) but have nucleic acid labels that are intentionally fragile or contain known degradation sites. For example, specific phosphodiester bonds within the subsequences are engineered to be hyper-sensitive to nucleases, or the detectable labels on the decoder probes are unusually prone to photobleaching. If the assay conditions (e.g., storage, washing, reagent quality) become suboptimal, these sentinel reagents will show a disproportionately rapid degradation of their temporal signal, or a distorted temporal sequence (e.g., certain steps fail prematurely). This provides an early warning indicator that the overall assay integrity is compromised, allowing for re-running the assay or flagging potentially unreliable results.
• Mermaid Diagram:

  stateDiagram-v2
      [*] --> Assay_Initialized
      Assay_Initialized --> Normal_Operation: Sentinel Signal Stable
      Normal_Operation --> Decoding_InProgress: Perform Multiplex Detection
      Decoding_InProgress --> Sentinel_Monitor_Active
      Sentinel_Monitor_Active --> Degradation_Threshold_Exceeded: Sentinel Signal Fails/Distorts
      Degradation_Threshold_Exceeded --> Alert_System: Integrity Compromised!
      Alert_System --> Rerun_Assay: Action Required
      Rerun_Assay --> Assay_Initialized
      Normal_Operation --> Results_Generated: All Signals Normal
      Results_Generated --> [*]: Report Valid Results
  

---

Derivatives for Claim 20 (Detection reagent):

Claim 20 defines a detection reagent comprising a probe reagent conjugated to a nucleic acid label with at least two different pre-determined subsequences for temporal detection.

Derivative 20.1: Universal Protein Scaffold for Nucleic Acid Label Attachment (Material & Component Substitution)

• Enabling Description: Instead of directly conjugating nucleic acid labels to diverse probe reagents (e.g., antibodies), a universal protein scaffold (e.g., SpyCatcher/SpyTag system, Affibody, Designed Ankyrin Repeat Protein (DARPin) based) is employed. This scaffold is engineered to have a high affinity binding site for a broad range of biotinylated probe reagents (e.g., via streptavidin fusion) on one end, and multiple highly specific and addressable conjugation sites (e.g., orthogonal click chemistry sites, unnatural amino acid incorporation for site-specific reactions) for the nucleic acid labels on the other end. The nucleic acid label itself could be a PNA (Peptide Nucleic Acid) for enhanced stability and binding. This modular design allows for rapid assembly of various detection reagents and simplifies manufacturing.
• Mermaid Diagram:

  classDiagram
      class UniversalScaffold {
          +ProbeBindingSite
          +NucleicAcidLabelConjugationSite[]
      }
      
      class ProbeReagent {
          +TargetBindingDomain
          +BiotinTag
      }
      
      class NucleicAcidLabel {
          +PNA_Backbone
          +Subsequence[]
          +ClickChemistryHandle
      }
      
      ProbeReagent --o UniversalScaffold : Binds via Biotin/Streptavidin
      NucleicAcidLabel --o UniversalScaffold : Covalently conjugated via Click Chemistry
      UniversalScaffold "1" -- "*" NucleicAcidLabel : Multiple labels per scaffold
      UniversalScaffold "1" -- "*" ProbeReagent : Multiple probes per scaffold (if multivalent)
  

Derivative 20.2: High-Density Nanoparticle Core with Encapsulated Nucleic Acid Labels (Operational Parameter Expansion)

• Enabling Description: The "detection reagent" is designed around a high-density, sub-50 nm nanoparticle core (e.g., gold nanoparticle, silica nanoparticle, upconverting nanoparticle). This core provides a large surface area for conjugating multiple probe reagents (e.g., 100s of antibodies). Crucially, the nucleic acid labels are not surface-conjugated but are encapsulated within the porous matrix of the nanoparticle itself. These encapsulated nucleic acid labels are protected from enzymatic degradation and harsh environmental conditions. They are released only upon specific triggering (e.g., pH change, light activation, enzymatic degradation of a sacrificial shell) into the local microenvironment for subsequent temporal decoding. This allows for high payload, robust reagents, and controlled release kinetics.
• Mermaid Diagram:

  graph TD
      A[Nanoparticle Core (e.g., Silica)] -- Porous Matrix --> B(Encapsulated Nucleic Acid Labels)
      A -- Surface Conjugation --> C[Multiple Probe Reagents (e.g., Antibodies)]
      B -- Triggered Release (e.g., pH, UV) --> D{Local Environment}
      D -- Diffuse --> E[Decoder Probes]
      E -- Hybridize --> D
      D -- Detect Temporal Sequence --> F(Analyte Identification)
      
      subgraph Detection Reagent
          A
          C
      end
  

Derivative 20.3: Biofouling Detection in Marine Sensors (Oceanography - Cross-Domain)

• Enabling Description: Detection reagents are integrated into anti-biofouling coatings for marine sensors. The "probe reagent" is a synthetic peptide or polymer embedded within the coating matrix, designed to specifically bind to early-stage biofouling organisms (e.g., bacterial adhesion proteins, algal extracellular polymeric substances) or their unique metabolic byproducts. These peptides/polymers are conjugated to nucleic acid labels. When biofouling occurs, the detection reagents bind to the target. A miniaturized, submersible temporal decoding unit periodically passes over the coated surface, applies decoder probes, and detects the temporal signatures. This allows for early, specific detection of biofouling types, triggering targeted, minimal intervention (e.g., localized UV burst, low-frequency sound pulse) rather than widespread, environmentally harmful antifoulants.
• Mermaid Diagram:

  flowchart LR
      A[Marine Sensor Surface] --> B{Anti-Biofouling Coating}
      B --> C[Embedded Detection Reagents (Probe+SeqTag)]
      C -- Bind to Biofouling Analytes --> D{Submersible Decoding Unit}
      D -- Periodically Scan --> E[Automated Fluidics (Decoder Probes)]
      E -- Temporal Decoding (Claim 12) --> F[Onboard Data Analysis]
      F --> G{Biofouling Alert & Characterization}
      G --> H(Targeted Anti-Fouling Intervention)
  

Derivative 20.4: Bio-Synthetic Hybrid Reagents for Adaptive Sensing (Integration with Emerging Tech)

• Enabling Description: The detection reagent is a bio-synthetic hybrid. The "probe reagent" is a live, engineered bacterium or yeast cell (a "sensing microbe") that expresses a surface receptor specific for a target analyte (e.g., a heavy metal ion, a specific pollutant). Upon binding the analyte, this microbe initiates a genetic circuit that results in the surface expression or secretion of multiple copies of a synthetic nucleic acid label. This nucleic acid label, containing the pre-determined subsequences, then becomes accessible for temporal decoding. The system could be further enhanced with AI optimization, where the AI dynamically adjusts the temporal decoding parameters based on the sensing microbe's metabolic activity, reported by IoT sensors integrated with the culture. This creates a living, adaptive biosensor with a synthetic readout mechanism.
• Mermaid Diagram:

  graph LR
      A[Target Analyte] --> B(Engineered Sensing Microbe)
      B -- Surface Receptor Binding --> C{Genetic Circuit Activation}
      C -- Express/Secrete --> D[Nucleic Acid Label (on Microbe Surface)]
      D --> E[Temporal Decoding System (Claim 12)]
      E --> F(Analyte Detection & Quantification)
      
      subgraph Bio-Synthetic Hybrid Detection Reagent
          B
          D
      end
      
      subgraph AI_Integration
          G[IoT Sensors (Microbe Metabolism)] --> H(AI Optimization)
          H --> E
      end
  

Derivative 20.5: Reagent with Built-in Quality Control (QC) Barcode (The "Inverse" or Failure Mode)

• Enabling Description: Each detection reagent is designed with an additional, short "QC subsequence" embedded within its nucleic acid label, distinct from the analyte-identifying subsequences. This QC subsequence is designed to be highly sensitive to common reagent degradation pathways (e.g., oxidation, nuclease contamination, pH extremes). During the first temporal decoding cycle, a specific QC decoder probe is always hybridized and detected. A robust signal from this QC subsequence confirms the integrity and functionality of the detection reagent itself (i.e., its nucleic acid label is intact and capable of hybridization). If the QC signal is absent or below a threshold, the entire batch of detection reagents is flagged as compromised, preventing false positives or negatives from faulty reagents. This provides a built-in quality control check for every individual detection reagent used in the assay.
• Mermaid Diagram:

  flowchart LR
      A[Detection Reagent (Probe + Nucleic Acid Label)]
      Nucleic_Acid_Label_Structure(Nucleic Acid Label)
      Nucleic_Acid_Label_Structure -- Contains --> B(Analyte_ID_Subsequence_1)
      Nucleic_Acid_Label_Structure -- Contains --> C(Analyte_ID_Subsequence_2)
      Nucleic_Acid_Label_Structure -- Contains --> D(QC_Subsequence)
      
      A --> E{Temporal Decoding (First Step)}
      E -- Hybridize QC Decoder Probe --> F(Detect QC Signal)
      F -- Signal > Threshold? --> G{Reagent OK}
      F -- Signal < Threshold? --> H{Reagent Failed QC}
      
      G -- Proceed --> I(Continue Analyte ID Decoding)
      H -- Discard --> J(Invalid Assay Result)
  

Derivative 20.6: Thermoplastic Polymer Matrix for Reversible Immobilization (Material & Component Substitution)

• Enabling Description: For in-situ applications, instead of a thermoset hydrogel, utilize a thermoplastic polymer matrix (e.g., polymethyl methacrylate (PMMA), polycarbonate) that is micro-perforated or has precisely engineered pores. Nucleic acid labels are derivatized with a UV-cleavable crosslinker to functional groups within this thermoplastic matrix. The advantage is that the matrix can be reversibly softened or dissolved (e.g., by mild heating or specific solvent washing) after detection, allowing for retrieval of the sample or embedded cellular components, or for re-analysis under different conditions. The "detectable label" on the decoder probes could be a surface-enhanced Raman scattering (SERS) tag, providing narrow, photostable spectral signals.
• Mermaid Diagram:

  graph TD
      A[Biological Sample] --> B(Embed in Thermoplastic Matrix)
      B -- UV-cleavable Crosslinker --> C[Detection Reagents w/ Nucleic Acid Labels]
      C --> D{Temporal Detection (SERS Labels)}
      D --> E[Data Analysis & Analyte Map]
      E --> F{Reversible Matrix Dissolution/Softening}
      F --> G(Sample Retrieval / Further Analysis)
  

Derivative 20.7: High-Pressure/High-Temperature Sterilization for Biohazard Detection (Operational Parameter Expansion)

• Enabling Description: The detection reagent is engineered for applications in extreme environments requiring robust sterilization, such as biosafety level 4 (BSL-4) facilities or extraterrestrial sample analysis. The "probe reagent" (e.g., heat-stable aptamer, synthetic peptide) and the nucleic acid label (e.g., PNA, LNA) are designed to withstand high-pressure (e.g., >200 MPa) and high-temperature (e.g., >121°C for autoclave sterilization) conditions without degradation. The conjugation method (e.g., robust covalent linkages like amide bonds, silane chemistry) must also be resistant. The detectable labels on the decoder probes are also selected for thermal and pressure stability. This ensures the reagents remain functional even after rigorous sterilization protocols, crucial for handling highly infectious agents or sensitive extraterrestrial samples.
• Mermaid Diagram:

  stateDiagram-v2
      [*] --> Reagent_Synthesis
      Reagent_Synthesis --> High_Pressure_High_Temp_Sterilization
      High_Pressure_High_Temp_Sterilization --> Sterile_Storage
      Sterile_Storage --> Contact_with_Biohazard_Sample: In BSL-4 / Space Environment
      Contact_with_Biohazard_Sample --> Analyte_Binding
      Analyte_Binding --> Temporal_Decoding: Robust reagents maintain function
      Temporal_Decoding --> Results_Generated
      Results_Generated --> [*]
  

Derivative 20.8: Time-Limited Reagent Functionality for Controlled Diagnostics (The "Inverse" or Failure Mode)

• Enabling Description: The detection reagent is engineered with an inherent, controlled degradation mechanism that limits its functional lifetime. This is useful for diagnostics where a precise window of activity is desired or to prevent prolonged environmental presence. The nucleic acid label, or its linker to the probe reagent, is designed with a bio-degradable polymer segment (e.g., polylactic acid, polycaprolactone) whose degradation rate is precisely calibrated to ambient environmental factors (e.g., temperature, humidity, light exposure). After a specific period (e.g., 24-48 hours), the nucleic acid label detaches or degrades, rendering the detection reagent non-functional and preventing further signal generation. This ensures that the diagnostic information is only available for a defined period, preventing misinterpretation of aged results or environmental contamination.
• Mermaid Diagram:

  graph TD
      A[Detection Reagent Synthesized] --> B(Degradable Linker/Component)
      B -- Initial State --> C[Active Analyte Binding]
      C --> D[Active Temporal Decoding]
      D -- Time Progresses --> E{Degradable Component Breakdown}
      E -- Leads to --> F(Nucleic Acid Label Loss/Degradation)
      F --> G[Reagent Non-Functional]
      G --> H(Dispose Safely)
  

---

Combination Prior Art Scenarios with Open-Source Standards

These scenarios illustrate how the core concepts of US 11,021,737 could be rendered obvious when combined with existing open-source standards and practices known to a PHOSITA prior to the patent's priority date (December 22, 2011).

Combination Prior Art Scenario 1: '737 Patent + Open-Source Image Processing Libraries (e.g., OpenCV, scikit-image)

• Enabling Description: The core of the '737 patent involves capturing a temporal sequence of images (e.g., fluorescent images, as mentioned in the patent) from a sample. An obvious improvement or application would be to process these images using widely available and well-documented open-source image processing libraries. For example, a PHOSITA would use OpenCV or scikit-image to perform:
  1. Image Registration: Aligning sequential images to correct for sample drift (explicitly mentioned as a challenge in the '737 patent: "position shift, such as less than 1 µm per amplicon"). Standard algorithms like phase correlation, SIFT, or ORB feature matching are readily available in these libraries.
  2. Noise Reduction: Applying Gaussian filters, median filters, or more advanced denoising algorithms to improve signal-to-noise ratio in low-light fluorescence images.
  3. Spot Detection and Segmentation: Identifying individual "spots" or clusters of signals (amplicons/detection reagents) using blob detection algorithms (e.g., Laplacian of Gaussian, Difference of Gaussians) and watershed segmentation.
  4. Signal Quantification: Extracting intensity values for each detected spot over the temporal sequence.
     This combination would render the act of computationally enhancing or correcting the detected temporal signals using standard image processing techniques as obvious.
• Mermaid Diagram:

  graph LR
      A[Raw Temporal Image Sequence] --> B(OpenCV/scikit-image)
      B -- Image Registration --> C[Drift-Corrected Image Sequence]
      C -- Noise Reduction --> D[Denoised Image Sequence]
      D -- Spot Detection & Segmentation --> E[Identified Signal Spots (X, Y, Z, Time)]
      E -- Signal Quantification --> F[Temporal Signal Profiles per Spot]
      F --> G(Analyte Identification Algorithm)
      G --> H(Output: Analyte Map)
  

Combination Prior Art Scenario 2: '737 Patent + Open-Source Microfluidics Design Platforms (e.g., LPKF CircuitCam/BoardMaster, various academic CAD tools for microfluidics)

• Enabling Description: The '737 patent frequently mentions microfluidic devices, flow cells, and automated fluidics for applying reagents and performing washes. Combining the '737 method with existing open-source design principles and platforms for microfluidics would be obvious for implementing the described methods in a practical, automated format. A PHOSITA skilled in microfluidics would use design tools (e.g., freely available CAD software, or open-source libraries for generating designs compatible with standard fabrication techniques like soft lithography, laser cutting) to create microfluidic chips that:
  1. Integrate Sample Inlet/Outlet: Standard ports for sample introduction and waste removal.
  2. Reagent Chambers and Mixing Channels: Efficiently mix detection reagents and decoder probes with the sample.
  3. Wash Channels: Perform rapid and efficient removal of unbound reagents, as required by the '737 method.
  4. Detection Zones: Optically transparent regions designed for imaging, compatible with the specified imaging systems.
  5. Temperature Control: Integrated micro-heaters or coolers for controlling hybridization/wash stringency.
     The creation of a microfluidic device to implement the fluidic steps of the '737 patent using commonly known design principles and open-source or freely available CAD tools would be obvious to a PHOSITA.
• Mermaid Diagram:

  flowchart TD
      A[Sample Input] --> M1(Microfluidic Inlet Port)
      B[Detection Reagent Input] --> M2(Microfluidic Reagent Port)
      C[Decoder Probe Input (Set 1..N)] --> M3(Microfluidic Decoder Port)
      D[Wash Buffer Input] --> M4(Microfluidic Wash Port)
      
      M1 & M2 & M3 & M4 --> MIX_CHANNELS[Mixing & Reaction Channels]
      MIX_CHANNELS --> DETECTION_ZONE[Optical Detection Zone]
      DETECTION_ZONE --> WASH_CHANNELS[Wash & Waste Channels]
      WASH_CHANNELS --> E[Waste Output]
      
      subgraph Microfluidic Device (Open-Source Design)
          M1 --- MIX_CHANNELS
          M2 --- MIX_CHANNELS
          M3 --- MIX_CHANNELS
          M4 --- WASH_CHANNELS
          MIX_CHANNELS --- DETECTION_ZONE
          DETECTION_ZONE --- WASH_CHANNELS
          WASH_CHANNELS --- E
      end
  

Combination Prior Art Scenario 3: '737 Patent + Open-Source Bioinformatics Tools for Sequence Design (e.g., Primer-BLAST, Biopython, ViennaRNA Package)

• Enabling Description: The '737 patent specifies that nucleic acid labels comprise "pre-determined subsequences" and that "the nucleic acid label can be designed for minimal cross-hybridization of bases with each other." It also describes designing decoder probes to be complementary. This process of designing specific nucleic acid sequences to avoid undesired secondary structures, minimize cross-hybridization, and optimize melting temperatures is a standard bioinformatics task. A PHOSITA would routinely use open-source bioinformatics tools for:
  1. Subsequence Design: Generating random or constrained sequences for the nucleic acid labels and decoder probes.
  2. Cross-Hybridization Prediction: Using tools like Primer-BLAST or similar algorithms to check for potential off-target binding between subsequences, decoder probes, and other nucleic acids in the sample.
  3. Secondary Structure Prediction: Employing software (e.g., ViennaRNA Package) to predict potential hairpin loops or other secondary structures within the nucleic acid labels or decoder probes that could interfere with hybridization.
  4. Melting Temperature (Tm) Calculation: Optimizing sequence length and GC content to achieve desired Tm for efficient hybridization and removal, as mentioned in the patent ("thermal denaturing can be reduced or avoided by using a sequencing-by-ligation approach and by setting the nucleic acid label base that immediately follows the sequencing primer...").
     The application of these well-known, open-source computational tools to design the specific nucleic acid sequences required by the '737 patent is a routine and obvious practice for anyone skilled in the art of molecular biology and oligonucleotide design.
• Mermaid Diagram:

  graph TD
      A[Design Requirements (e.g., length, multiplex level)] --> B(Generate Candidate SeqTag Subsequences)
      B --> C{Biopython: Sequence Manipulation}
      C --> D{Primer-BLAST: Cross-Hybridization Check}
      C --> E{ViennaRNA: Secondary Structure Prediction}
      C --> F{Custom Script: Tm Optimization}
      D -- Fail --> B
      E -- Fail --> B
      F -- Fail --> B
      D & E & F -- Pass --> G[Validated SeqTag & Decoder Probe Sequences]
      G --> H(Synthesize Nucleic Acid Labels & Decoder Probes)
      H --> I(Fabricate Detection Reagents)
      I --> J(Perform '737 Method)